Company profile
Clementia Pharmaceuticals company profile
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. The company develops disease-modifying treatments for patients suffering from debilitating bone and other diseases with a high unmet medical need. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues. Clementia Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.
Business identity
- Contact email
- [email protected]
- Phone number
- (514) 940-3600
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 5,001-10,000 employees
- Revenue range
- $1M-$10M
- Founded
- 2010-01-01
Headquarters
- Headquarters
- Maple Bay, British Columbia, Canada
- Postal code
- H3Z 2Y5
- Country code
- CA
- Continent
- North America